Monthly Archives: April 2016

Biopharmaceutical News Week 15- 2016

    Zika virus   US Centers for Disease Control and Prevention (CDC) confirmed earlier studies by a French team that infection with the Zika virus in pregnant women is a cause of birth defects and other severe brain abnormalities in babies “There isn’t any doubt that Zika causes microcephaly” said CDC’s Director Tom Frieden […]

read more

Biopharmaceutical News Week # 14 – 2016

      Acquisitions /mergers/joint-ventures   Pfizer and Allergan have confirmed that have mutually agreed to terminate their proposed $160 billion merger indicating that the decision was driven by new rules from the US government. By moving its legal domicile from the US to Ireland, where Allergan is based, Pfizer would have been able to […]

read more

Biopharmaceutical News Week 16- 2016

       Zika virus   Protein Sciences (Meriden, CT, USA) announces a collaboration with Sinergium Biotech and Mundo Sano both located in Argentina to advance the development of its Zika vaccine   Acquisitions /mergers/joint-ventures   According to the Sunday Times AstraZeneca has made a formal offer worth around £7 billion to acquire Medivation (South […]

read more

Biopharmaceutical News Week 13-1016

    Zika virus   According to a study by the Centers of Disease Control and Prevention (CDC), Zika may spread further north on the North America continent than previously thought. The Aedes aegypty species could reach as far north as San Francisco, Kansas City and New York City, the Aedes albopictus species could stretch […]

read more